Publication:
HLA-B27 Polymorphism in Turkish Patients with Ankylosing Spondylitis

dc.authorscopusid6701577980
dc.authorscopusid55935835200
dc.authorscopusid22333972200
dc.authorscopusid7003532093
dc.contributor.authorBirinci, A.
dc.contributor.authorBilgici, A.
dc.contributor.authorKuru, Ö.
dc.contributor.authorDurupínar, B.
dc.date.accessioned2020-06-21T15:29:17Z
dc.date.available2020-06-21T15:29:17Z
dc.date.issued2006
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Birinci] Asuman, Department of Microbiology and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bilgici] Ayhan, Department of Physical Medicine and Rehabilitation, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kuru] Ömer, Department of Physical Medicine and Rehabilitation, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Durupínar] Belma, Department of Microbiology and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThe aim of this study was to determine the distribution of human leukocyte antigen (HLA)-B27 subtypes in serologically HLA-B27-positive ankylosing spondylitis (AS) patients and healthy controls from the Turkish population and to compare this with other reports from other populations. We subtyped HLA-B27 in 38 HLA-B27-positive Turkish patients with AS and 47 HLA-B27-positive healthy controls without AS by polymerase chain reaction with specific sequence primers (PCR-SSP). The results demonstrated that: B*2705 was the predominant subtype among both of the patients (71.1%) and controls (68.0%). B*2702 was observed in 26.3% and 32.0% of the patients and controls, respectively. B*2708 subtype was found in 2.6% of the patients but not among the control group. When the distribution of B27 subtypes in Turkish populations was compared with that in other populations, similar frequencies with the Caucasian-Europe groups were noted. However, this should be interpreted carefully because of the small number of individuals in our study. © Springer-Verlag 2005.en_US
dc.identifier.doi10.1007/s00296-005-0614-x
dc.identifier.endpage287en_US
dc.identifier.issn0172-8172
dc.identifier.issue4en_US
dc.identifier.pmid16032389
dc.identifier.scopus2-s2.0-30744436312
dc.identifier.scopusqualityQ2
dc.identifier.startpage285en_US
dc.identifier.urihttps://doi.org/10.1007/s00296-005-0614-x
dc.identifier.volume26en_US
dc.identifier.wosWOS:000234601600002
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofRheumatology Internationalen_US
dc.relation.journalRheumatology Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectB*2702en_US
dc.subjectB*2705en_US
dc.subjectB*2708en_US
dc.subjectHLA-B27en_US
dc.subjectHuman Leukocyte Antigenen_US
dc.subjectSubtypesen_US
dc.titleHLA-B27 Polymorphism in Turkish Patients with Ankylosing Spondylitisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files